Abu Dhabi Health Services Company (SEHA), the UAE’s largest healthcare network, welcomed medical experts to a Grand Rounds Event titled ‘Use of Stem Cells in the Treatment of Spinal Cord Injury’ with Dr. Mohamad Bydon, M.D., Neurosurgeon and Professor of Neurologie Surgery, Orthopedic Surgery, and Health Services Research.

The one-hour session was hosted at Sheikh Shakhbout Medical City, and is based on the recently released study by Mayo Clinic, on a Phase 1 Trial of Autologous Adipose Tissue–Derived Mesenchymal Stem Cells in the Treatment of Paralysis Due to Traumatic Spinal Cord Injury. The Grand Rounds event highlighted findings of the report following examination of the recovery process of an American male, aged 53-years, who sustained considerable trauma to his spinal cord following a surfing accident. Injuries included complete loss of motor and sensory function below the level of injury along with loss of bowel and bladder sensation. The patient underwent a C2-6 posterior cervical decompression and fusion. Despite achieving recovery, the patient could not regain a positive quality of life.

The patient – after consent - was enrolled into the multidisciplinary CELLTOP clinical trial nine months after his accident. Before enrollment, the patient’s neurologic status was found to be ASIA grade C. Imaging revealed bilateral myelomalacia at the C3 level as well as the C2-6 decompression and fusion. The CELLTOP clinical trial involved isolating Mesenchymal stem cells from an adipose tissue biopsy specimen, then expanded and cryopreserved internally in the Mayo Clinic Immune, Progenitor, and Cell Therapeutics Laboratory.

Attendees of the event were able to see the results and success of the CELLTOP program, in addition to the diagnostic applications used in treating the patient. Stem Cell research has remarkable implications on treatment of various degenerative diseases, and this session will showcase its use in treating previously challenging medical conditions. 

Dr. Mohamad Bydon is a globally-recognized expert in minimally invasive spine surgery (MIS) for a variety of spinal conditions, including back pain and neck pain, spinal stenosis, and spinal fusion.He is also a principal investigator of the Mayo Clinic Neuro-Informatics Laboratory, which focuses on data analytics, patient safety, surgical outcomes, and novel therapeutic treatments for degenerative spine disease and spinal cord injury. Dr. Bydon is also medical director of the Mayo Clinic Neurosurgical Registry, a database focused on improving outcomes and safety for patients.

© Press Release 2020

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.